Natesto (Nasal Testosterone)
Acerus, the fertility-sparing option
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- FDA Approved (Natesto)
Reference only. Not medical advice.
What can go wrong
Adherence burden (three times daily). Nasal irritation, rhinorrhea, epistaxis. Not for men with significant nasal/sinus disease.
This is something to take to a clinician. The Atlas can tell you what is known about natesto (nasal testosterone) in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Natesto (Acerus Pharmaceuticals) is an intranasal testosterone gel dosed three times daily. Its distinguishing feature is pharmacokinetic: the short, pulsatile peaks from nasal dosing appear to avoid the sustained HPG suppression that other formulations cause, so LH/FSH and spermatogenesis are often preserved, a real advantage for men who want TRT without losing fertility. The trade-offs are the three-times-daily schedule (adherence) and nasal side effects (rhinorrhea, irritation). It is one of the more clinically interesting formulations precisely because of the fertility data.
The one testosterone that may not tank your sperm count.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
Safety in detail
Requires physician oversight and monitoring. Three-times-daily dosing adherence is essential.
What it does to fertility
Uniquely among testosterone products, the short pulsatile nasal dosing tends to preserve LH/FSH and spermatogenesis in many men, a genuine fertility advantage being actively studied.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Total testosterone
- Hematocrit
- Semen analysis if fertility relevant
What people get wrong
Often saidAll testosterone destroys fertility
ActuallyMost do, but Natesto's pulsatile nasal pharmacokinetics often preserve LH/FSH and sperm production, the one notable exception, under study.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Route
- Intranasal gel, 3x daily
- Distinguishing feature
- Tends to preserve LH/FSH & fertility
- Trade-off
- Frequent dosing; nasal effects
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Natesto (Nasal Testosterone). A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.